Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1
- 1 February 2002
- journal article
- case report
- Published by Springer Nature in Leukemia
- Vol. 16 (2) , 276-283
- https://doi.org/10.1038/sj.leu.2402372
Abstract
A spontaneously EBV transformed follicular lymphoma (FL) cell line, Tat-1, was established from the lymph node biopsy specimen of a patient with B cell FL, grade 1 in transformation to high grade disease. Tat-1 cells expressed lymphoid markers and developed tumor masses in immunodeficient mice. Bcl-2, Bcl-X(L), Bax and p53 protein expression was revealed by Western blotting. Flow cytometric analysis confirmed P-gp expression. Cytogenetically, the Tat-1 cell line showed identical chromosomal alterations to that of the initial biopsy specimen, among which the most notable were the t(14;18) typical of FL and additional abnormalities involving chromosomes 1, 8 and 13. Multicolor FISH analysis delineated all abnormalities, including a t(1p;8q), a der(8)(8q24::14q32::18q21) and a der(13)(13q32::8q24::14q32::18q21). Further FISH investigations using a locus-specific probe cocktail containing c-myc, IgH and bcl-2 revealed fusion of these three loci on the derivatives 8 and 13, in addition to the derivative 14 IgH/bcl-2 fusion and an extra copy of c-myc on derivative chromosome 1. These results demonstrate an additional example of the deregulation of bcl-2 and c-myc expression through recombination with a single IgH enhancer region. The unusual molecular features of the Tat-1 cell line render it a unique tool for studies focused on cytogenetic alterations, expression of multidrug resistance phenotype and expression of anti-apoptotic proteins in FL.Keywords
This publication has 28 references indexed in Scilit:
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresBlood, 2001
- Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)Genes, Chromosomes and Cancer, 2001
- High-Grade Malignant Non-Hodgkin’s Lymphomas Differ from Low-Grade Lymphomasin the Extent of Apoptosis andTheir Expression of bcl-2, mcl-1,bax and p53Tumor Biology, 1998
- CHANGES IN Bcl-2 AND p53 EXPRESSION IN RECURRENT B-CELL LYMPHOMASThe Journal of Pathology, 1996
- Current management of follicular lymphomaCurrent Opinion in Oncology, 1996
- Comparison of Cytogenetic Analysis, Southern Analysis, and Polymerase Chain Reaction for the Detection of t(14; 18) in Follicular LymphomaAmerican Journal of Clinical Pathology, 1995
- Multistep transformation in low-grade lymphoproliferative diseasesAnnals of Oncology, 1993
- Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)Nature, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987